Jiangsu Aikang Biomedical R&D

Aikang Biomedical is a biotechnology company based in Jiangsu, China, specializing in the research and development of innovative small molecule drugs. The company focuses primarily on anti-viral therapies, with a significant emphasis on developing treatments for chronic Hepatitis B. In addition to its internal drug discovery programs, Aikang Biomedical provides contract research services (CRO) to the global pharmaceutical industry, leveraging its expertise in medicinal chemistry and synthetic organic chemistry. The firm operates out of the Nanjing Jiangbei New Area, positioning itself within a major Chinese life sciences hub to facilitate collaborations and rapid development.